PDF下载 ( 206 KB)
Etanercept combined with prednisolone for treatment of rheumatoid arthritis with liver cirrhosis resulting from autoimmune hepatitis: a case report
-
摘要:
<正>类风湿关节炎合并自身免疫性肝炎临床上较为少见。现将收治的1例类风湿关节炎合并自身免疫性肝炎后肝硬化患者结合文献对其临床、实验室特点及治疗方案进行总结,以资共鉴。1病例资料患者女性,55岁,因"反复四肢多关节肿痛12年"于2015
-
Key words:
- arthritis /
- rheumatoid /
- hepatitis /
- autoimmune /
- etanercept
-
[1]ALETAHA D,NEOGI T,SILMAN AJ,et al.2010 Rheumatoid arthritis classification criteria:an American College of Rheumatology/European League Against Rheumatism collaborative initiative[J].Arthritis Rheum,2010,62(9):2569. [2]JOHNSON PJ,Mc FARLANE IG.Meeting report:International autoimmune hepatitis group[J].Hepatology,1993,18:998-1005. [3]Chinese Society of Hepatology,Chinese Medical Association;Chinese Society of Gastroenterology,Chinese Medical Association;Chinese Society of Infectious Diseases,Chinese Medical Association.Consensus on the diagnosis and management of autoimmune hepatitis(2015)[J].J Clin Hepatol,2016,32(1):9-22.(in Chinese)中华医学会肝病学分会,中华医学会消化病学分会,中华医学会感染病学分会.自身免疫性肝炎诊断和治疗共识(2015)[J].临床肝胆病杂志,2016,32(1):9-22. [4]SMOLEN JS,LANDEWR,BREEDVELD FC,et al.EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs:2013 update[J].Ann Rheum Dis,2014,73(3):492-509. [5]ZENG XF,ZHU SL,TAN AC,et al.Disease burden and quality of life of rheumatoid arthritis in China:a systematic review[J].Chin J Evid-based Med,2013,13(3):300-307.(in Chinese)曾小峰,朱松林,谭爱春,等.我国类风湿关节炎疾病负担和生存质量研究的系统评价[J].中国循证医学杂志,2013,13(3):300-307. [6]WANG S.Clinical observation on effect of biological agent etanercept cmbined with methotrexate in treatment of refractory rheumatoid arthritis[J].Chongqing Med,2013,42(26):3100-3101,3104.(in Chinese)汪珊.生物制剂益赛普联合甲氨蝶呤治疗难治性类风湿关节炎的疗效观察[J].重庆医学,2013,42(26):3100-3101,3104. [7]CHENG JW,LI XF,ZHANG LY,et al.The clinical efficacy and safety of short-term combination therapy with etanercept,methotrexate and cyclophosphamide for rheumatoid arthritis[J].Chin J Rheumatol,2008,12(7):480-483.(in Chinese)陈俊伟,李小峰,张莉芸,等.短期益赛普与甲氨蝶呤环磷酰胺联合治疗类风湿关节炎的临床研究[J].中华风湿病学杂志,2008,12(7):480-483. [8]CHERAVSKY AC,PALADINO N,RUBIO AE,et al.Simultaneous expression of Th1 cytokines and IL-4 confers severe characteristics to type I autoimmune hepatitis in children[J].Hum Immunol,2004,65(7):683-691. [9]CALABRESE LH.Molecular differences in anticytokine therapies[J].Clin Exp Rheumatol,2003,21(2):241-248. [10]KLINKHOFF A.Biological agents for rheumatoid arthritis:targeting both physical function and structural damage[J].Drugs,2004,64(12):1267-1283. [11]SPADARO A,SCRIVO R,RICCIERI V,et al.Effect of tumor necrosis factor alpha antagonists in a patient with rheumatoid arthritis and primary biliary cirrhosis[J].Joint Bone Spine,2008,75(1):87-89. [12]SOKKA T,HETLAND ML,MKINEN H,et al.Remission and rheumatoid arthritis:data on patients receiving usual care in twenty-four countries[J].Arthritis Rheum,2008,58(9):2642-2651. [13]LUTF A,POIL AR,HAMMOUDEH M.Characteristics of patients with rheumatoid arthritis in Qatar:a cross-sectional study[J].Int J Rheum Dis,2014,17(1):63-65. [14]WANG GY,ZHANG SL,WANG XR,et al.Remission of rheumatoid arthritis and potential determinants:a national multi-center crosssectional survey[J].Clin Rheumatol,2015,34(2):221-230. [15]EFE C.Drug induced autoimmune hepatitis and TNF-αblocking agents:is there a real relationship?[J].Autoimmun Rev,2013,12(3):337-339. [16]OZORIO G,Mc GARITY B,BAK H,et al.Autoimmune hepatitis following infliximab therapy for ankylosing spondylitis[J].Med J Aust,2007,187(9):524-526. [17]HARADA K,AKAI Y,KOYAMA S,et al.A case of autoimmune hepatitis exacerbated by the administration of etanercept in the patient with rheumatoid arthritis[J].Clin Rheumatol,2008,27(8):1063-1066. -
本文二维码
计量
- 文章访问数: 626
- HTML全文浏览量: 9
- PDF下载量: 122
- 被引次数: 0
下载:
